Home › Multiple Sclerosis › Oklahoma › Oklahoma City
Multiple Sclerosis clinical trials in Oklahoma City, OK
3 studies for Multiple Sclerosis are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Skeletal Muscle Aging and Responsiveness in Aged People With MS
Recruiting
- Oklahoma Medical Research Foundation, Oklahoma City
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
RecruitingPhase 2
- Local Institution - Site 105, Oklahoma City
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
RecruitingPhase 2
- Oklahoma Medical Research Foundation (OMRF) MS Center of Excellence, Oklahoma City
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH10 studies
- Birmingham, AL9 studies
- Aurora, CO8 studies
- Kansas City, KS8 studies
- St. Louis, MO8 studies
- San Francisco, CA8 studies
- Tampa, FL7 studies
- Dallas, TX7 studies
Other studies in Oklahoma City
- Non-Small Cell Lung Cancer32 studies
- Ovarian Cancer29 studies
- Endometrial Cancer28 studies
- Colorectal Cancer22 studies
- Prostate Cancer22 studies
- Lung Cancer20 studies
- Breast Cancer18 studies
- Metastatic Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Cancer (all types)15 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Bladder Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.